Invention Grant
US07960409B2 Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
失效
药用苯基喹啉和色烯-2-酮三唑化合物
- Patent Title: Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
- Patent Title (中): 药用苯基喹啉和色烯-2-酮三唑化合物
-
Application No.: US12012246Application Date: 2008-02-01
-
Publication No.: US07960409B2Publication Date: 2011-06-14
- Inventor: Erich L. Grimm , Yves Ducharme , Richard Frenette , Richard Friesen , Marc Gagnon , Helene Juteau , Sebastien Laliberte , Bruce MacKay , Yves Gareau
- Applicant: Erich L. Grimm , Yves Ducharme , Richard Frenette , Richard Friesen , Marc Gagnon , Helene Juteau , Sebastien Laliberte , Bruce MacKay , Yves Gareau
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Mollie M. Yang; Valerie J. Camara
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4192 ; C07D487/04 ; C07D401/06
Abstract:
The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors. Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
Public/Granted literature
- US20080188521A1 Novel pharmaceutical compounds Public/Granted day:2008-08-07
Information query
